Tumor necrosis factor production pathway

The **tumor necrosis factor production pathway** refers to a complex network of molecular events that regulate the synthesis and release of tumor necrosis factor-alpha (**TNF**, also known as **TNF-alpha**), a key pro-inflammatory cytokine. This is not a single molecule or receptor but an entire biological process involving multiple genes, transcription factors, post-transcriptional regulators, and cell types. The main function is to mediate immune responses—including inflammation, apoptosis, cell proliferation/survival—and it plays critical roles in both normal physiology and disease states such as cancer and chronic inflammatory conditions. Dysregulation can lead to pathological inflammation seen in diseases like rheumatoid arthritis or sepsis. Therapeutic interventions usually target individual proteins within this cascade—most notably **TNF itself** or its receptors (**TNFR1**, **TNFR2**)—rather than the overall "production pathway"[1][2][3]. Because “tumor necrosis factor production pathway” is not a discrete molecular entity but rather describes an entire regulatory process/network leading to cytokine expression/release/action, it should not be considered a canonical therapeutic target in drug discovery databases; instead focus should be placed on individual molecules such as “Tumor necrosis factor” (**TNF**) or “Tumor necrosis factor receptor 1” (**TNFR1**)[3].

Other names

TNF production pathwayTumor necrosis factor-alpha (TNF-α) signaling pathwayTNF signaling cascade